Investigating the link between COVID-19 and diabetes development
CODA: COvid and Diabetes Assessment
This study is looking to see how COVID-19 might affect the development and worsening of Type 1 and Type 2 diabetes, and it's inviting both kids and adults who have recently been diagnosed with diabetes—whether or not they've had COVID-19—to join in and share their health information.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11072747 on NIH RePORTER |
What this research studies
This research focuses on understanding how COVID-19 infection may contribute to the onset and progression of Type 1 and Type 2 diabetes. It aims to recruit a diverse group of patients, both adults and children, who have recently been diagnosed with diabetes and have either had a known COVID-19 infection or have not been infected in the past year. By utilizing a national network of health systems and diabetes centers, the study will gather data through electronic health records and regular surveys to analyze the biological processes involved. Participants will be contacted through various methods to ensure a comprehensive and inclusive recruitment process.
Who could benefit from this research
Good fit: Ideal candidates include individuals diagnosed with Type 1 or Type 2 diabetes within the last three months, particularly those who have had a COVID-19 infection recently.
Not a fit: Patients who were diagnosed with diabetes more than three months ago or those who have never had a COVID-19 infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of diabetes in patients who have had COVID-19.
How similar studies have performed: Other research has indicated a potential link between viral infections and diabetes onset, suggesting this approach may yield valuable insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Rothman, Russell L. — Vanderbilt University Medical Center
- Study coordinator: Rothman, Russell L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.